Essential Medicines & Devices Lists
Prices and Patents
Our Recommendations
- Essential Package of Health Services (EPHS). Secondary & Tertiary Care: The District, County & National Health Systems (Liberia) (2011)
- الأدوية الأساسية (2022)
- MSF Médicaments Essentiels - Guide pratique d'utilisation 2022 (2022)
- Sources And Prices Of Selected Medicines for Children (2010)
- MSF Essential Drugs - Practical Guidelines 2022 (2022)
New Publications
- Liste nationale des médicaments essentiels et autres produits de santé (2023) (2023)
- A review of health-care waste management policies in the Western Pacific Region: key findings from selected countries and areas (2024)
- Landscape analysis of pregnancy exposure registries in low- and middle-income countries (2024)
- Medication safety for look-alike, sound-alike medicines (2023)
- Certified African Regional professionals: Level 1 Biorisk Management (2023)
Filter
373
Featured
Recommendations
50
New Publications
108
Language
Document type
Guidelines
196
Studies & Reports
58
Manuals
52
Resource Platforms
18
Training Material
16
Strategic & Response Plan
10
Fact sheets
10
Online Courses
7
Videos
3
No document type
2
Infographics
1
Countries / Regions
Latin America and the Carribbean
13
South Africa
11
India
9
Kenya
8
Global
7
Ethiopia
7
Ghana
6
Liberia
5
Sierra Leone
4
Nigeria
4
Africa
4
Tanzania
4
Eastern Europe and Central Asia
4
Western and Central Europe
4
Argentina
4
Nepal
3
Ukraine
3
Rwanda
3
Burkina Faso
3
Brazil
3
Somalia
3
Myanmar / Burma
3
China
2
Cameroon
2
Fiji
2
Senegal
2
Guinea
2
Mozambique
2
Guinea-Bissau
2
Congo, Democratic Republic of
2
Uganda
2
Russia
2
Sudan
2
Mali
2
Angola
2
Zambia
2
North Macedonia
1
Tajikistan
1
Serbia
1
Australia
1
Benin
1
Kazakhstan
1
Kyrgyzstan
1
Uzbekistan
1
Malaysia
1
Zimbabwe
1
Mongolia
1
Philippines
1
Armenia
1
South–East Asia Region
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Bangladesh
1
Vietnam
1
Papua New Guinea
1
Georgia
1
Central African Republic
1
Libya
1
Bhutan
1
South Sudan
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
66
Guidelines
20
Infection Control & Prevention (IPC)
19
Waste Management
16
Laboratory Quality Assurance
16
Laboratory Waste
10
Medical Devices & Equipment
10
Pharmaceutical Assessments
9
Paediatrics
8
Medicines Donations
7
Pediatrics
7
Pharmacy & Technologies
7
Pharmacy & Technology
6
COVID-19
6
Family Planning
5
Emergency Health Kits
4
Disease Prevention & Control
4
General Guidelines
3
Maternal & Child Health
3
Policies
3
Studies & Reports
3
NTDs & Others
3
Maternal Health
3
Parasitology
3
Neonatal Care
3
Reproductive Health
3
Hand Hygiene
2
Online Courses & Platforms
2
Vaccine-preventable Diseases
2
Chagas
2
Information, Education and Communication (IEC)
2
Capacity Building
2
WASH
2
General Guidelines
2
Primary Health Care
2
Leishmaniasis
2
Child Health
1
Diabetes
1
Trachoma
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Antimicrobial Resistance
1
Lymphaticfilariasis
1
Cancer
1
Monitoring & Evaluation
1
Cancer Treatment & Resources
1
Snakebites
1
Countries
1
Health System Strengthening
1
NCD
1
Diarrhoeal Disease/Cholera
1
Clinical Guidelines
1
Women & Child Health
1
Other
1
Respiratory Infections
1
Immunization
1
Quality Control & Assurance
1
Surgery & Anaesthesia
1
Gynaecology & Obstetrics
1
Leprosy
1
Neurology & Psychology
1
Age & Elderly
1
Global Health
1
TB
1
Toolboxes
Rational use of Medicine
52
Essential Medicines & Devices Lists
50
Pharmacy Practice
43
Waste Managment
43
Essential Medicines
30
Supply Chain & Store Management
28
Traditional & Herbal Medicines
28
Standard Operating Procedures (SOPs)
27
General Guidelines for Rational Use
24
Quality Assurance
23
Falsified & Substandard
22
Pharmacovigilance
21
Pharmacy Management
19
Reports & Studies
17
Waste Management
14
Resource Platforms
12
Pharmaceutical Assessments
11
Essential Medicines & Medical Devices
9
Prices and Patents
8
Medicine Donations
7
Online Courses
7
IPC
5
Model Formulary
5
Pharmaceutical Dosage Forms
5
Various Target Groups
5
Infection Prevention & Hygiene
4
Essential List
4
Country specific documents
4
Immunization Guidelines
4
Logistics & Supply
4
Human Rights & the Right to Health
4
Infection Control
4
WASH
3
Clinical Guidelines
3
Diagnostics & Laboratory Guidance
3
Standard Operating Procedure (SOP)
3
Pharmacy
3
Guidelines & Manuals
3
Emergency health kits
3
Emergency health kits
3
Clinical Guidelines
3
Assessment
3
Surveillance
2
Country specific
2
Public Health
2
Standard Precautions
2
International
2
Studies
2
Hand Hygiene
2
Infection Control General
2
Training, others
2
For Health Worker
2
Access & Strategy
2
Hand Hygiene
2
Water Pollution
2
Chagas
2
Leishmaniasis
2
Studies & Reports
2
Drug resistant TB
2
Stewardship
2
Clinical Guidelines
2
Treatment Guidelines
1
Laboratory Guidance
1
Adults
1
Policies & Programmes
1
Context, Facts & Travel Advice
1
Children
1
Platforms and initiatives
1
General Studies & Reports
1
Tools for Rational use
1
Cholera Prevention & Control
1
Training
1
Children
1
Health & Refugee
1
Cholera
1
Treatment Guidelines
1
General
1
Online Courses & Resources
1
Covid-19 & the One Health Approach
1
Covid-19 & Climate Change
1
For Pregnant Women
1
Global Impact: Socio-economic, health services, TB & HIV
1
Hospital Readiness/Essential Health Services
1
Vaccine Candidates & Research
1
Psychosocial Support
1
mRna Vaccines general
1
Vector-based Vacines General
1
Research & Pipeline
1
Online Courses
1
Videos
1
Women & Maternal Health
1
Argentina
1
Mental Disorders
1
Capacity Building
1
Antimicrobial Resistance (AMR)
1
General
1
Health Care In Conflict Settings
1
Waste management
1
Strategies & Roadmaps
1
Overview, Studies & Reports
1
Global Overview
1
War Surgery & Wound Care
1
Malnutrition
1
Diarrhoea
1
Education of students & professionals
1
Cholera
1
Public Health
1
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Its main objectives are: to explain the educational approach underlying the Guide; to explain how to teach pharmacotherapy with the Guide; to give practical advice on how to assess the students, the teachers and the course; and to assist in mobilizing support for problem-based pharmacotherapy teachi...
The ICAT is a simple and practical approach for assessing the adequacy of existing infection prevention and control practices and provides specific recommendations for improving practices and monitoring their effectiveness over time
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
The document contains a set of indicators that can be used for monitoring traditional and complementary medicine (T&CM) systems in a country.
The core indicator set consists of 16 indicators that were considered essential and collectively able to provide information on T&CM inputs, processes and ou...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there...
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate ...
Accessed on 15.08.2022
La farmacovigilancia es una herramienta que permite la detección, evaluación, conocimiento y prevención de efectos adversos y/o inesperados de los medicamentos que se prescriben. También facilita la detección de fallas de respuesta terapéutica por deficiencias de calid...
Ukrainian Title:
УКРАЇНА: Еквівалентність лікарських засобів, зареєстрованих в Україні та інших країнах. Інформація для працівників охорони здоров'я та пацієнтів
To support t...
Little progress has been made since the 1960s and 1970s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and operational challenges in the clinica...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
Leishmaniasis is a spectrum of disease caused by the infection of protozoan parasite Leishmania mainly affecting the antigen presenting cell of the host. The disease is although considered as neglected tropical disease still it is not completely eradicated. Majority of the issues related to the ther...
High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulati...
Un évènement de santé publique grave (PHE) consiste en une flambée quelconque ou en toute
autre situation en évolution rapide qui peut avoir un impact négatif sur la santé humaine et exiger
une évaluation et des actions immédiates. Le terme prend en compte tout évènement n’ayant pas
...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and i...
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and i...
Medication errors are a leading cause of patient harm globally. WHO launched the Global Patient Safety Challenge: Medication Without Harm, with the objective of preventing severe medication related patient harm globally. This publication is one of the documents in the WHO Technical Series on “Medi...
Many vaccines and drugs hold the promise of reducing mortality and morbidity among pregnant women and infants living in low- and middle-income countries (LMICs). However, sufficient information on the safety of drugs and vaccines in pregnant women is rarely available at the time of product licensure...
